Format

Send to

Choose Destination
Gut. 2016 Jul;65(7):1230-2. doi: 10.1136/gutjnl-2016-311452. Epub 2016 Feb 26.

Spleen size for the prediction of clinical outcome in patients with primary sclerosing cholangitis.

Author information

1
1st Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany Department of Interdisciplinary Endoscopy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
2
1st Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
3
AP-HP, Hôpital Saint-Antoine, Service d'Hépatologie, Reference Center for Inflammatory Biliary Diseases, Sorbonne Universités, UPMC Univ Paris 06, UMR_S 938, Paris, France.
4
Department of Radiology, Saint-Antoine Hospital, Paris, France Pierre and Marie Curie University-Paris 6. Faculté de médecine Pierre et Marie Curie, Paris France.
5
Department of Medical Biometry and Epidemiology, University Medical Center Hamburg Eppendorf, Hamburg, Germany.
6
Department of Interdisciplinary Endoscopy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

KEYWORDS:

BILIARY CIRRHOSIS; IMMUNE-MEDIATED LIVER DAMAGE; PRIMARY SCLEROSING CHOLANGITIS; ULTRASONOGRAPHY

PMID:
26921347
DOI:
10.1136/gutjnl-2016-311452
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center